1. Home
  2. GPCR vs BATRA Comparison

GPCR vs BATRA Comparison

Compare GPCR & BATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

HOLD

Current Price

$41.33

Market Cap

3.9B

Sector

N/A

ML Signal

HOLD

Logo Atlanta Braves Holdings Inc. Series A

BATRA

Atlanta Braves Holdings Inc. Series A

HOLD

Current Price

$54.44

Market Cap

3.4B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
GPCR
BATRA
Founded
2016
1991
Country
United States
United States
Employees
N/A
1610
Industry
Broadcasting
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.4B
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
GPCR
BATRA
Price
$41.33
$54.44
Analyst Decision
Strong Buy
Buy
Analyst Count
12
2
Target Price
$103.17
$60.00
AVG Volume (30 Days)
844.0K
69.2K
Earning Date
05-08-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$12.40
Revenue Next Year
N/A
$8.54
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.80
$41.50
52 Week High
$94.90
$54.58

Technical Indicators

Market Signals
Indicator
GPCR
BATRA
Relative Strength Index (RSI) 31.79 70.47
Support Level $30.82 $45.81
Resistance Level $57.23 N/A
Average True Range (ATR) 2.62 1.36
MACD -0.32 0.04
Stochastic Oscillator 4.61 97.81

Price Performance

Historical Comparison
GPCR
BATRA

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

About BATRA Atlanta Braves Holdings Inc. Series A

Atlanta Braves Holdings Inc is a holding company. It operates through its wholly-owned subsidiary, which is the owner and operator of the Atlanta Braves Major League Baseball Club and the mixed-use real estate development, The Battery Atlanta, and is the operator of the Atlanta Braves Major League Baseball Club's stadium, Truist Park. The company predominantly derives revenue related to the Braves baseball franchise and Truist Park from ticket sales, concessions, local broadcasting rights, advertising sponsorships, suites and premium seat fees, retail and licensing revenue, shared MLB revenue streams, including national broadcasting rights and licensing, and other sources. The company's reportable segments include: Baseball which generates key revenue, and Mixed-Use Development.

Share on Social Networks: